相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project
Corinne Willame et al.
DRUG SAFETY (2021)
The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety
Steven B. Black et al.
VACCINE (2021)
Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots
Jacqui Wise
BMJ-BRITISH MEDICAL JOURNAL (2021)
Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis
Daniel R. Morales et al.
LANCET DIGITAL HEALTH (2021)
Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension
George Hripcsak et al.
JAMA INTERNAL MEDICINE (2020)
Principles of Large-scale Evidence Generation and Evaluation across a Network of Databases (LEGEND)
Martijn J. Schuemie et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2020)
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study
Jennifer C. E. Lane et al.
LANCET RHEUMATOLOGY (2020)
Data resource profile: JMDC claims databases sourced from Medical Institutions
Katsuhiko Nagai et al.
JOURNAL OF GENERAL AND FAMILY MEDICINE (2020)
Guillain-Barre syndrome in Denmark: validation of diagnostic codes and a population-based nationwide study of the incidence in a 30-year period
Lotte Sahin Levison et al.
CLINICAL EPIDEMIOLOGY (2019)
Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis
Marc A. Suchard et al.
LANCET (2019)
Incidence study of Guillain-Barre syndrome in the province of Ferrara, Northern Italy, between 2003 and 2017. A 40-year follow-up
Enrico Granieri et al.
NEUROLOGICAL SCIENCES (2019)
How to perform a meta-analysis with R: a practical tutorial
Sara Balduzzi et al.
EVIDENCE-BASED MENTAL HEALTH (2019)
Data Resource Profile: Clinical Practice Research Datalink (CPRD)
Emily Herrett et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2015)
Feasibility and utility of applications of the common data model to multiple, disparate observational health databases
Erica A. Voss et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2015)
VALIDITY AND LIMITATIONS OF THE LONGITUDINAL PATIENT DATABASE FRANCE FOR USE IN PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMICS STUDIES
S. L. Jouaville et al.
VALUE IN HEALTH (2015)
Optum Labs: Building A Novel Node In The Learning Health Care System
Paul J. Wallace et al.
HEALTH AFFAIRS (2014)
Estimation of Background Incidence Rates of Guillain-Barre Syndrome in Germany - A Retrospective Cohort Study with Electronic Healthcare Data
Sabrina Hense et al.
NEUROEPIDEMIOLOGY (2014)
The incidence of narcolepsy in Europe: Before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns
Leonoor Wijnans et al.
VACCINE (2013)
Post-licensure rapid immunization safety monitoring program (PRISM) data characterization
Meghan A. Baker et al.
VACCINE (2013)
Validation of a common data model for active safety surveillance research
J. Marc Overhage et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2012)
Use of population based background rates of disease to assess vaccine safety in childhood and mass immunisation in Denmark: nationwide population based cohort study
Thomas A. Rasmussen et al.
BRITISH MEDICAL JOURNAL (2012)
Guillain-Barre syndrome: background incidence rates in The Netherlands
Nicoline A. T. van der Maas et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2011)
Active Surveillance for Adverse Events: The Experience of the Vaccine Safety Datalink Project
W. Katherine Yih et al.
PEDIATRICS (2011)
Interpretation of random effects meta-analyses
Richard D. Riley et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies
Nicola P. Klein et al.
VACCINE (2010)
Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines
Steven Black et al.
LANCET (2009)